Daniel M. Junius
2014
In 2014, Daniel M. Junius earned a total compensation of $3.1M as President and Chief Executive Officer at ImmunoGen, a 30% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $310,365 |
---|---|
Option Awards | $2,248,535 |
Salary | $544,500 |
Other | $8,184 |
Total | $3,111,584 |
Junius received $2.2M in option awards, accounting for 72% of the total pay in 2014.
Junius also received $310.4K in non-equity incentive plan, $544.5K in salary and $8.2K in other compensation.
Rankings
In 2014, Daniel M. Junius' compensation ranked 2,920th out of 13,032 executives tracked by ExecPay. In other words, Junius earned more than 77.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,920 out of 13,032 | 78th |
Division Manufacturing | 1,036 out of 4,966 | 79th |
Major group Chemicals And Allied Products | 334 out of 1,686 | 80th |
Industry group Drugs | 259 out of 1,365 | 81st |
Industry Pharmaceutical Preparations | 213 out of 1,043 | 80th |
Source: SEC filing on September 29, 2015.
Junius' colleagues
We found five more compensation records of executives who worked with Daniel M. Junius at ImmunoGen in 2014.
2014
David Johnston
ImmunoGen
Chief Financial Officer
2014
John Lambert
ImmunoGen
Executive Vice President and Distinguished Research Fellow
2014
Gregory Perry
ImmunoGen
Chief Financial Officer
2014
James O'Leary
ImmunoGen
Chief Medical Officer
2014
Charles Morris
ImmunoGen